Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China
· Delayed Price · Currency is CNY 70.65
+1.64 (2.38%)
Mar 10, 2026, 9:45 AM CST
SHE:300573 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,006 | 12,229 | 22,715 | 11,076 | 11,263 | 7,612 | Upgrade
|
| Market Cap Growth | 32.66% | -46.16% | 105.08% | -1.66% | 47.96% | 29.71% | Upgrade
|
| Enterprise Value | 16,761 | 11,973 | 22,352 | 10,579 | 11,226 | 7,679 | Upgrade
|
| Last Close Price | 69.01 | 48.70 | 89.40 | 43.39 | 47.03 | 32.62 | Upgrade
|
| PE Ratio | 26.28 | 36.17 | 94.63 | 52.33 | 57.85 | 86.52 | Upgrade
|
| PS Ratio | 7.06 | 6.29 | 15.48 | 8.86 | 10.96 | 11.05 | Upgrade
|
| PB Ratio | 9.16 | 7.68 | 13.44 | 7.14 | 8.38 | 10.97 | Upgrade
|
| P/TBV Ratio | 9.94 | 8.38 | 14.09 | 7.27 | 8.52 | 11.56 | Upgrade
|
| P/FCF Ratio | 41.53 | 56.03 | 408.51 | - | 53.15 | 543.47 | Upgrade
|
| P/OCF Ratio | 26.75 | 29.33 | 71.53 | 38.69 | 36.69 | 62.32 | Upgrade
|
| EV/Sales Ratio | 6.96 | 6.16 | 15.23 | 8.46 | 10.92 | 11.15 | Upgrade
|
| EV/EBITDA Ratio | 19.12 | 23.95 | 65.68 | 35.59 | 37.73 | 48.73 | Upgrade
|
| EV/EBIT Ratio | 21.81 | 29.32 | 85.99 | 45.76 | 46.72 | 68.51 | Upgrade
|
| EV/FCF Ratio | 40.93 | 54.85 | 401.97 | - | 52.98 | 548.27 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.14 | 0.05 | 0.01 | 0.08 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.42 | 0.23 | 0.05 | 0.36 | 0.51 | Upgrade
|
| Debt / FCF Ratio | 0.33 | 0.99 | 1.42 | - | 0.53 | 5.71 | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.10 | -0.24 | -0.32 | -0.43 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.28 | -0.31 | -1.18 | -1.69 | -1.93 | 0.27 | Upgrade
|
| Net Debt / FCF Ratio | -0.60 | -0.71 | -7.22 | 38.70 | -2.71 | 3.05 | Upgrade
|
| Asset Turnover | 1.05 | 0.94 | 0.77 | 0.72 | 0.78 | 0.76 | Upgrade
|
| Inventory Turnover | 2.96 | 2.93 | 2.64 | 2.52 | 2.85 | 2.54 | Upgrade
|
| Quick Ratio | 1.51 | 1.41 | 2.83 | 4.69 | 3.23 | 0.94 | Upgrade
|
| Current Ratio | 1.90 | 1.80 | 3.48 | 5.68 | 3.69 | 1.39 | Upgrade
|
| Return on Equity (ROE) | 37.08% | 20.59% | 14.81% | 14.62% | 20.52% | 14.73% | Upgrade
|
| Return on Assets (ROA) | 20.85% | 12.30% | 8.54% | 8.33% | 11.33% | 7.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 41.91% | 25.63% | 20.13% | 23.01% | 27.40% | 15.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 40.00% | 24.50% | 14.70% | 14.20% | 16.90% | 14.90% | Upgrade
|
| Earnings Yield | 3.80% | 2.76% | 1.06% | 1.91% | 1.73% | 1.16% | Upgrade
|
| FCF Yield | 2.41% | 1.79% | 0.24% | -0.12% | 1.88% | 0.18% | Upgrade
|
| Dividend Yield | 1.13% | 2.20% | 2.11% | 1.26% | 0.50% | 0.28% | Upgrade
|
| Payout Ratio | 68.05% | 138.01% | 74.36% | 38.19% | 24.21% | 18.41% | Upgrade
|
| Buyback Yield / Dilution | -0.66% | -0.70% | -0.96% | -7.45% | 0.30% | -2.88% | Upgrade
|
| Total Shareholder Return | 0.46% | 1.50% | 1.15% | -6.19% | 0.80% | -2.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.